Dr. Molly Mulligan is director of business development at Redwire’s In Space Manufacturing and Operations business unit. In this role, she supports business development efforts for the company’s biotechnology and materials science portfolio.
Prior to joining Redwire, Dr. Mulligan worked at Space Commerce Matters as the Director of Commercialization Strategies, where she led efforts in commercial allocation and commercialization strategies. In 2017, Dr. Mulligan returned to the United States and began working for the Center for the Advancement of Science in Space (CASIS). CASIS manages the US National Lab located on the International Space Station (ISS).
In 2014, Dr. Mulligan’s expertise in the area of tissue chips led her to join SpacePharma, a start-up company in Herzliya Israel, that builds hardware for research platforms based in space.
Dr. Mulligan did her post-doctoral work in Biomedical Engineering at the Technion - Israel Institute of Technology. At the Technion, Dr. Mulligan’s work focused on tissue chips, this time looking at breathing lung models. Dr. Mulligan attended the University of Massachusetts Amherst (UMass), where she earned a PhD in Mechanical Engineering in 2011, and Smith College ('05), where she double majored in Physics and Astronomy.